Newstral
Article
Forbes on 2020-04-10 23:58
Gilead’s Drug Remdesivir Shows Hope In Treating Coronavirus Patients, But Data Is Limited
Related news
- The Challenges of Treating COVID-19: Lessons from Gilead’s RemdesivirForbes
- WHO advises against Gilead’s remdesivir for all hospitalized COVID-19 patientsreuters.com
- Fauci: Gilead’s remdesivir can block coronavirusrockrivertimes.com
- FFDA gives emergency authorisation to Gilead’s remdesivirft.com
- BGilead’s Remdesivir Supply Won’t Meet U.S. Need, Analyst Saysbarrons.com
- FDA Issues Emergency Use Authorization For Gilead’s Coronavirus Treatment RemdesivirForbes
- BGilead’s Remdesivir Isn’t Enough to Drive Its Stock Higherbarrons.com
- US approves Gilead’s remdesivir drug for coronavirus patients ― Trumpvanguardngr.com
- BThe Market Is Overreacting to Gilead’s Coronavirus Drug Remdesivir, Analysts Saybarrons.com
- MInfectious disease doctors ask government to explain how it decides who gets Gilead’s remdesivirmarketwatch.com
- New therapy offers hope for cancer patients with limited treatment optionsexpressandstar.com
- Experimental drug remdesivir shows ‘hopeful’ signs in small group of coronavirus patientspressherald.com
- MHow Gilead’s remdesivir became the leader in the rush to find a treatment for COVID-19marketwatch.com
- BFDA Expands Emergency Use of Gilead’s Remdesivir in All Covid-19 Hospitalizationsbarrons.com
- U.S. emergency approval broadens use of Gilead’s COVID-19 drug remdesivirThe Japan Times
- FCoronavirus latest: Gilead’s remdesivir becomes first FDA approved Covid-19 drugft.com
- Gilead’s remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in someamny.com
- Two-thirds of coronavirus patients improve after drug remdesivir, study saysNew York Post
- Report: Covid-19 patients recovering quickly after getting experimental drug remdesivirCNN